The following items discuss the MRC trials. For items relating to a more general discussion of clinical research, click here.
Letter discussing a patient with myelomatosis. The patient had myelomatosis since June 1976 and had been in the 3rd MRC trial. Galton discusses treating the patient with weekly cyclophosphamide. Note: contains only page 1 of the letter; missing remaining page(s).
Letter discussing Galton’s opinion of Vindesine in treatment and the MRC Working Party’s interferon trials.
Letter providing notes on the treatment of a 51-year-old patient from the MRC 3rd trial, including detailed information on dosage and schedule. At the end, Galton provides a brief update on the case of another patient, alias Mr. Doe, whose back was irradiated.
Letter discussing miscellaneous topics, including publishing in the Lancet, the MRC trial, and a patient Galton intends to start on the Brandes regimen.